↓ Skip to main content

Non-inferiority of dose reduction versus standard dosing of TNF-inhibitors in axial spondyloarthritis

Overview of attention for article published in Arthritis Research & Therapy, January 2019
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news
4 news outlets
twitter
3 X users

Citations

dimensions_citation
44 Dimensions

Readers on

mendeley
52 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Non-inferiority of dose reduction versus standard dosing of TNF-inhibitors in axial spondyloarthritis
Published in
Arthritis Research & Therapy, January 2019
DOI 10.1186/s13075-018-1772-z
Pubmed ID
Authors

Jordi Gratacós, Caridad Pontes, Xavier Juanola, Jesús Sanz, Ferran Torres, Cristina Avendaño, Antoni Vallano, Gonzalo Calvo, Eugenio de Miguel, Raimon Sanmartí

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 52 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 52 100%

Demographic breakdown

Readers by professional status Count As %
Other 8 15%
Librarian 4 8%
Researcher 4 8%
Professor > Associate Professor 3 6%
Student > Master 3 6%
Other 11 21%
Unknown 19 37%
Readers by discipline Count As %
Medicine and Dentistry 20 38%
Pharmacology, Toxicology and Pharmaceutical Science 3 6%
Nursing and Health Professions 3 6%
Biochemistry, Genetics and Molecular Biology 1 2%
Unspecified 1 2%
Other 4 8%
Unknown 20 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 32. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 February 2019.
All research outputs
#1,228,635
of 25,385,509 outputs
Outputs from Arthritis Research & Therapy
#117
of 3,381 outputs
Outputs of similar age
#28,629
of 446,389 outputs
Outputs of similar age from Arthritis Research & Therapy
#5
of 76 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,381 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.2. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 446,389 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 76 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.